Clinical trial

Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation

NCT06027307

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-10-25

PhasePHASE3

Study timeline

Study start (actual)2023-10-25Date precision: day

Registry last updated2025-12-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tricuspid Regurgitationunresolved

Heart Failure With Preserved Ejection Fractionunresolved

Interventions

EnavogliflozinDRUG

PlaceboDRUG

Sponsors & collaborators

Asan Medical Centerlead sponsor

Daewoong Pharmaceutical Co. LTD.collaborator

Mapped research locations

SeoulSouth Korea4 IncheonSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06027307 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.